Abstract
Judy M. Bradley*1; Kathryn Ferguson2; Katherine O’Neill*1; Denise
Cosgrove2; Adam T. Hill*3; Michael R. Loebinger*4; Mary Carroll*5;
James D. Chalmers*6; Timothy Gatheral*7; Chris Johnson*8; Anthony
De Soyza*9; John R. Hurst*10; Andrew Bailey11; Joseph S. Elborn*1
1Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine,
Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, United
Kingdom; 2Belfast Health and Social Care Trust, Belfast, United Kingdom; 3Royal
Infirmary and University of Edinburgh, Edinburgh, United Kingdom; 4Royal
Brompton Hospital and Imperial College London, London, United Kingdom;
5University Hospital Southampton NHS Foundation Trust, Southampton, United
Kingdom; 6University of Dundee, College of Medicine, Dundee, United Kingdom;
7Department of Respiratory Medicine, University Hospitals of Morecambe Bay NHS
Foundation Trust, Morecambe Bay, United Kingdom; 8Cambridge Centre for Lung
Infection, Papworth Hospital, Cambridge, United Kingdom; 9Institute of Cellular
Medicine, Newcastle University, National Institute of Health Research Biomedical
Research Centre, Newcastle, United Kingdom; 10UCL Respiratory, University
College London, London, United Kingdom; 11Frontier Science (Scotland) Ltd.,
Kincraig, United Kingdom
*On behalf of BRONCH-UK consortium
Judy M. Bradley*1; Katherine O’Neill*1; Kathryn Ferguson2; Adam T.
Hill*3; Michael R. Loebinger*4; Mary Carroll*5; Timothy Gatheral*6;
Anthony De Soyza*7; James D. Chalmers*8; Chris Johnson*9; John R.
Hurst*10; Jeremy Brown10; Andrew Bailey11; Joseph S. Elborn*1
1Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine,
Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, United
Kingdom; 2Belfast Health and Social Care Trust, Belfast, United Kingdom; 3Royal
Infirmary and University of Edinburgh, Edinburgh, United Kingdom; 4Royal
Brompton Hospital and Imperial College London, London, United Kingdom;
5University Hospital Southampton NHS Foundation Trust, Southampton,
United Kingdom; 6Department of Respiratory Medicine, University Hospitals
of Morecambe Bay NHS Foundation Trust, Morecambe Bay, United Kingdom;
7Institute of Cellular Medicine, Newcastle University, National Institute of Health
Research Biomedical Research Centre, Newcastle, United Kingdom; 8University
of Dundee, College of Medicine, Dundee, United Kingdom; 9Cambridge Centre
for Lung Infection, Papworth Hospital, Cambridge, United Kingdom; 10UCL
Respiratory, University College London, London, United Kingdom; 11Frontier
Science (Scotland) Ltd., Kincraig, United Kingdom
*On behalf of BRONCH-UK consortium
Cosgrove2; Adam T. Hill*3; Michael R. Loebinger*4; Mary Carroll*5;
James D. Chalmers*6; Timothy Gatheral*7; Chris Johnson*8; Anthony
De Soyza*9; John R. Hurst*10; Andrew Bailey11; Joseph S. Elborn*1
1Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine,
Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, United
Kingdom; 2Belfast Health and Social Care Trust, Belfast, United Kingdom; 3Royal
Infirmary and University of Edinburgh, Edinburgh, United Kingdom; 4Royal
Brompton Hospital and Imperial College London, London, United Kingdom;
5University Hospital Southampton NHS Foundation Trust, Southampton, United
Kingdom; 6University of Dundee, College of Medicine, Dundee, United Kingdom;
7Department of Respiratory Medicine, University Hospitals of Morecambe Bay NHS
Foundation Trust, Morecambe Bay, United Kingdom; 8Cambridge Centre for Lung
Infection, Papworth Hospital, Cambridge, United Kingdom; 9Institute of Cellular
Medicine, Newcastle University, National Institute of Health Research Biomedical
Research Centre, Newcastle, United Kingdom; 10UCL Respiratory, University
College London, London, United Kingdom; 11Frontier Science (Scotland) Ltd.,
Kincraig, United Kingdom
*On behalf of BRONCH-UK consortium
Judy M. Bradley*1; Katherine O’Neill*1; Kathryn Ferguson2; Adam T.
Hill*3; Michael R. Loebinger*4; Mary Carroll*5; Timothy Gatheral*6;
Anthony De Soyza*7; James D. Chalmers*8; Chris Johnson*9; John R.
Hurst*10; Jeremy Brown10; Andrew Bailey11; Joseph S. Elborn*1
1Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine,
Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, United
Kingdom; 2Belfast Health and Social Care Trust, Belfast, United Kingdom; 3Royal
Infirmary and University of Edinburgh, Edinburgh, United Kingdom; 4Royal
Brompton Hospital and Imperial College London, London, United Kingdom;
5University Hospital Southampton NHS Foundation Trust, Southampton,
United Kingdom; 6Department of Respiratory Medicine, University Hospitals
of Morecambe Bay NHS Foundation Trust, Morecambe Bay, United Kingdom;
7Institute of Cellular Medicine, Newcastle University, National Institute of Health
Research Biomedical Research Centre, Newcastle, United Kingdom; 8University
of Dundee, College of Medicine, Dundee, United Kingdom; 9Cambridge Centre
for Lung Infection, Papworth Hospital, Cambridge, United Kingdom; 10UCL
Respiratory, University College London, London, United Kingdom; 11Frontier
Science (Scotland) Ltd., Kincraig, United Kingdom
*On behalf of BRONCH-UK consortium
Original language | English |
---|---|
Pages | 6 |
Publication status | Published - 2020 |
Event | 4th World Bronchiectasis & NTM Conference - Virtual Event Duration: 16 Dec 2020 → 19 Dec 2020 Conference number: 4 http://www.world-bronchiectasis-conference.org/ |
Conference
Conference | 4th World Bronchiectasis & NTM Conference |
---|---|
Period | 16/12/2020 → 19/12/2020 |
Internet address |